Mills credited SailPoint's long-time CEO Mark McClain with keeping the ship steady throughout the IPO journey, calling him "a ...

Investors in defense stocks seem a bit nervous at the prospect ... Well, simply put, because Anduril might IPO soon. Since its establishment in 2017 (by, among others, Oculus founder Palmer ...

Wall Street loves a perfectly choreographed IPO, with more shares offered and prices increased in the lead-up to the deal, to ...

The AI company debuted on the Nasdaq with $410.7m. Another example includes CeriBell, a medical device maker with an EEG platform that uses AI to monitor patient seizures that priced its IPO at ...

First Trust International IPO ETF has a consensus price target of $51.01, indicating a potential upside of 0.00%. Given First Trust International IPO ETF’s stronger consensus rating and higher ...

The data startup is using AI to forecast startup funding, acquisitions and public offerings—but its biggest challenge may be ...

Clearly, if you had been lucky enough to pick up some shares at the company’s IPO price, you would have ... perform relative to some other popular stocks? Also, find out which stocks you should ...

Pitanium Limited's $7.9M U.S. IPO shows slow growth, high valuation, and financial challenges. Click here to find out why ...

Stocks, sectors, strategies, and themes that have had a dream run post the covid-19 pandemic are in the grips of selling pressure. The pressure has extended to initial public offerings (IPOs ...

Aardvark is only the latest biotech looking to squeeze through the slowly widening IPO window. This morning will also see Hong Kong-listed Ascentage try its luck on the Nasdaq via a $126.4 million ...

Obesity biotech Aardvark eyes IPO as Ascentage makes $126M Nasdaq debut There’s also another commonality—all the companies going public have planned timelines to their next catalyst ...

Drugs Made In America Acquisition Corp. announced the completion of its initial public offering, raising $200 million by selling 20 million units at $10 each, which began trading on Nasdaq under ...